Atlas Trials

Doxycycline for Hereditary Hemorrhagic Telangiectasia

Clinical trial NCT03397004 · COMPLETED

Trial details

NCT number
NCT03397004
Sponsor
Unity Health Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hereditary Hemorrhagic Telangiectasia (HHT)
Start date
2018-09-12
Primary completion
2021-02-18
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.